Mission Pet Health Review 2026: What Sellers Should Know Before Deciding

Mission Pet Health Review 2026: What Sellers Should Know Before Deciding

Key takeaways

  • Mission Pet Health is the combined successor to Southern Veterinary Partners (SVP) and Mission Veterinary Partners (MVP) — formally merged December 2024, unified brand launched July 2025, backed by Shore Capital Partners and Silver Lake at an approximately $8.6 billion valuation.
  • Scale: 840-plus hospitals across 40-plus US states as of 2026, making Mission Pet Health one of the largest veterinary platforms in the country and among the most active acquirers of general-practice hospitals.
  • Their published model commits to not changing your hospital’s name, brand, or culture and preserves clinical autonomy — consistent with the legacy SVP partnership approach that defined both predecessor organizations.
  • Deal structures are flexible and individually negotiated — Mission states explicitly that “no partnership structure is the same.” Cash at closing, retained equity, and earnout arrangements are all possible components depending on the practice and the owner’s goals.
  • A direct offer from Mission is one data point, not a ceiling. Owners who run a structured competitive process consistently see the total economic outcome expand versus accepting a single-buyer term sheet without exploring the broader field.

The most common version of this conversation starts the same way every time I encounter it. An owner gets a call or an email from Mission Pet Health‘s outreach team — sometimes they’ve been following the practice for a year, sometimes the message comes out of nowhere.

The offer sounds compelling. Mission is professional, they have real infrastructure, and they say the right things about keeping your name on the door and letting you run medicine your way.

And then the owner does something understandable. They sit with that term sheet for a few weeks, maybe share it with their spouse, maybe call their CPA.

But they don’t know what the comparable benchmarks are. They don’t know how Mission’s offer stacks up against the broader buyer pool.

And they often make a decision before they’ve ever seen what the competitive market actually produces for a practice like theirs.

This piece is designed to fill that gap. A Mission Pet Health review for sellers: who they are, where they came from, how they approach acquisitions in 2026, and what to think about before you decide whether their offer is the right one for you.

What is Mission Pet Health — a 2026 review of who they are and where they came from

Mission Pet Health is a PE-backed veterinary group formed by the December 2024 merger of Southern Veterinary Partners (SVP) and Mission Veterinary Partners (MVP). The unified brand launched publicly on July 21, 2025, replacing both predecessor names.

SVP was founded in 2014 in Birmingham, Alabama. Shore Capital Partners, a Chicago-based PE firm, partnered with Dr.

Jay Price — a veterinarian and practice owner — to launch the platform with 3 clinics. By 2023, SVP had grown to more than 400 practices, concentrated in the Southeast and Sun Belt states.

MVP was formed in 2017 in Southfield, Michigan, via a combination of two regional groups, and expanded to more than 330 practices with broader national reach than SVP had at the time.

The two platforms were both Shore Capital investments. In late 2024, Shore and Silver Lake completed a recapitalization that valued the combined platform at approximately $8.6 billion and merged SVP and MVP into a single operating entity (Bloomberg, November 2024; Axios, November 2024).

Dr. Jay Price, SVP’s founder, became CEO of the combined organization.

The Mission Pet Health brand began rolling out publicly at missionpethealth.com on August 4, 2025.

As of 2026, Mission Pet Health operates more than 840 hospitals across more than 40 US states, employing over 20,000 people (Birmingham Business Journal, August 2025). A May 2026 real estate transaction — Four Corners Property Trust’s agreement to acquire up to 102 Mission Pet Health properties across 31 states for $268 million — provides an independent third-party confirmation of the platform’s national footprint and financial stability (BusinessWire, May 2026).

A veterinarian reviewing a written offer document at a practice desk, looking down at papers, candid scene with warm natural light

How Mission Pet Health’s 2026 acquisition model actually works

Mission Pet Health states explicitly that it offers flexible deal structures and that “no partnership structure is the same.” This language, published on their partnerships page, reflects the legacy of both SVP and MVP — two organizations that built their reputations largely on individually negotiated, co-ownership-oriented transactions rather than one-size-fits-all deals.

The core published commitments from Mission Pet Health to selling practice owners are:

  • No change to hospital name, brand, or logo — Mission states directly that they will not rebrand your practice.
  • Clinical autonomy preserved — Mission does not dictate treatment protocols or how veterinarians practice medicine.
  • Staff and culture continuity — the team you’ve built stays in place; Mission commits to not altering team culture.
  • Back-office support added — HR, recruiting, marketing, inventory management, and finance support migrate to Mission’s central infrastructure.

The deal timeline Mission describes is: 30 to 45 days for valuation after initial information submission, and 90 to 120 days to closing from a signed letter of intent. Those are direct-transaction timelines — a single buyer, moving on its own schedule.

What Mission does not publish is the specific economic structure of any given offer — the cash-at-close percentage, the retained-equity arrangement, or any earnout mechanics. Mission’s own materials state that structure varies by practice.

That is accurate: deal terms in any PE-backed acquisition are individually negotiated, and the specific outcome on any one variable depends heavily on how the conversation begins and whether it is a direct-offer conversation or a competitive one.

For a deeper look at how deal components like earnout and rollover equity work across the PE-backed buyer pool generally, the veterinary practice earnout and rollover equity guide covers the mechanics in plain language.

What Mission Pet Health looks for in a practice in 2026

Mission Pet Health describes its ideal partner as a “growth-oriented and long-term-focused” practice. Beyond that language, no minimum revenue or EBITDA threshold appears in their published materials — but the platform’s operating economics suggest that smaller single-doctor practices are unlikely to draw significant attention in 2026, while well-run multi-doctor practices with strong financials, clean operations, and a stable team represent the profile Mission consistently prioritizes.

A few factors that commonly shape how any major PE-backed buyer evaluates a general practice:

Revenue and EBITDA profile. Practices generating meaningful normalized EBITDAthe operating profit after stripping out owner compensation above market rate and personal expenses run through the practice — are valued as multiples of that number. The stronger the normalized EBITDA, the larger the total transaction value.

Team depth. Mission is acquiring a revenue-generating system, not just a single clinician. Practices where production is distributed across multiple veterinarians are structurally more transferable and more valuable than single-doctor practices where all revenue flows through the owner’s hands.

Clean financial documentation. Mission’s valuation process involves their own financial review. Practices with clearly documented financials, low owner-dependency, and straightforward P&Ls move faster and attract cleaner offers.

Geographic fit. With 840-plus hospitals already in the network, Mission concentrates its 2026 acquisition activity on markets where it either has no footprint yet or where a new addition strengthens an existing cluster. Strong practices in markets Mission actively wants tend to draw more competitive internal enthusiasm than practices in already-saturated geographies.

To understand where your practice falls on the valuation spectrum before any buyer conversation, the veterinary practice valuation guide walks through the normalized EBITDA methodology buyers actually use.

The competitive process question that matters most in 2026

Here’s the pattern I see consistently when a practice owner receives a direct Mission Pet Health term sheet. The offer looks substantial.

Mission is professional. The commitments they make about autonomy and culture are reassuring.

And the owner, working in good faith, starts mentally treating that offer as the market.

It isn’t. It’s one buyer’s view of what the practice is worth in a conversation where they’re the only bidder.

The specific structure and terms of any Mission Pet Health offer are negotiated case by case and become fully visible only when compared against other qualified bids. Mission participates in structured competitive processes run by qualified sell-side advisors alongside direct conversations. Their offers in competitive contexts often look different from their direct-approach term sheets — not because Mission changes its model, but because all buyers, across the board, calibrate their offers to the leverage they perceive in any given conversation.

How PE-backed buyers price veterinary practices covers the dynamics that drive that gap. And the consolidator landscape guide provides broader context on where Mission sits relative to the full buyer pool.

The question owners should be asking isn’t “is Mission Pet Health a good buyer?” — they are a serious, well-capitalized buyer. The question is: “Is a direct Mission offer the best economic outcome available to my specific practice in this specific market?”

A veterinarian and a sell-side advisor reviewing deal terms together at a table, papers spread out, candid natural light, focused expressions

A Mission Pet Health review benchmark: how direct offers compare to competitive outcomes

The table below summarizes the structural differences between a direct Mission Pet Health approach and what a competitive process with multiple qualified bidders typically produces. The numbers in the right column are not specific to Mission — they reflect the general pattern across PE-backed buyers when a qualified sell-side process is run.

FactorDirect Mission Pet Health offerCompetitive process outcome
Buyers in the room14-8+ qualified bidders
Offer calibrated toBuyer’s internal valuation modelCompetitive market clearing price
Total value visibilitySingle data pointFull market range visible
Deal structure flexibilityMission’s preferred termsMultiple term sheets to compare
Timeline to close90-120 days (direct)Compressed by competitive pressure
Who sets termsMissionSeller, via bidding leverage

The gap between a direct offer and what the same practice clears in a structured process consistently runs into real money — often seven figures — on any meaningful practice. That gap is not theoretical.

It shows up in our work across the deals we’ve run over the past four-plus years.

For context on what who to sell your veterinary practice to covers the full decision framework across buyer types.

How Mission Pet Health’s integration approach affects sellers post-close in 2026

Mission Pet Health is mid-integration in 2026. The December 2024 merger of SVP and MVP brought together two organizations with distinct regional operating structures, vendor relationships, central-services platforms, and management teams. That integration is real and ongoing.

For sellers considering a Mission Pet Health transaction in 2026, a few things are worth understanding about what post-close looks like:

Brand stability. Mission’s commitments on this are explicit and consistent with both legacy organizations’ track records. SVP built a multi-year reputation for allowing acquired hospitals to retain their local names and reputations.

Mission inherits that approach and has codified it publicly.

Clinical autonomy. Mission’s published materials state they do not dictate treatment protocols. This too is consistent with the legacy partnership model.

Operational structure. Back-office functions migrate to Mission’s central infrastructure post-close. This covers HR, recruiting, finance, inventory, and marketing support.

Owners should understand clearly which decisions remain at the practice level and which shift to the regional or national structure.

Integration timing. Acquisitions completed during an active integration period sometimes experience changes to vendor relationships, regional management contacts, and support structures as the combined platform rationalizes its operations. Owners should ask specifically about the integration roadmap and what changes are expected at the practice level in the 12 months post-close.

None of these dynamics make Mission Pet Health a wrong choice for any given seller. They are the factual context that an informed seller should have before the conversation begins.

What a Mission Pet Health offer actually includes

EBITDAthe operating profit your practice earns before taxes and accounting choices — is the foundation of any PE-backed valuation. The multiplethe multiplier buyers apply to EBITDA to set the total price — is what varies by buyer type, deal structure, and competitive context.

Mission Pet Health does not publish a standard price sheet. In the processes where Mission participates as a bidder alongside other qualified buyers, competitive outcomes for strong multi-doctor general practices reflect the full PE-backed market for practices of that size and profile.

We discuss what PE-backed buyers are paying generally — the ranges, the variables, and the drivers — in the PE pricing guide for veterinary practices.

Deal structure components that commonly appear in PE-backed veterinary transactions include:

Cash at close. The majority of total deal value is typically paid as wire-transferred funds directly to the seller at closing. The exact percentage is individually negotiated.

Rollover equity. Some sellers retain a stake of ownership in the practice or the combined platform post-close — keeping a slice of ownership in the new entity instead of taking all cash at close. The retained stake is intended to provide upside at Mission’s future exit event, at a valuation and timing determined by Mission and its PE sponsors.

Rollover equity is illiquid until that exit.

Earnout. An earnoutpart of the sale price paid later, only if the practice hits agreed performance targets after closing — is a possible component of some transactions. Earnout terms vary significantly and are individually negotiated.

Clean, specific performance targets and caps matter enormously to the seller’s actual economic outcome.

Understanding how these components interact, and how they compare across multiple buyers simultaneously, requires seeing more than one term sheet.

What the competitive process produces that a direct offer can’t

When the Elite Selling System — our structured competitive bidding process — is run for a practice in the qualifying revenue band, we hand-select and vet every buyer who gets to bid, the way a doorman with a velvet rope lets in only the right people. Mission Pet Health is among the institutional PE-backed buyers that participates when the practice profile fits their criteria.

So are several other major buyers active in 2026.

What that field of qualified bidders produces is visibility: the full range of what your practice is worth in today’s market, not just what it’s worth to Mission on a Tuesday when they’re the only buyer at the table.

Practices in the qualifying size range that run a structured process consistently clear materially better total economic outcomes than the same practice would have achieved by accepting a direct term sheet without exploring the field. The gap is not a function of Mission being a lesser buyer — it’s a function of competition forcing every buyer to bring their best number.

That is the math behind sell my veterinary practice as a decision, versus accept the first term sheet. The arithmetic matters.

What to do before you respond to a Mission Pet Health offer

The most expensive mistake I see practice owners make is this: they treat the arrival of a Mission Pet Health term sheet as the beginning of a negotiation with Mission. It isn’t.

It’s the beginning of a negotiation with the full market — or it should be.

Before you respond to any direct offer from Mission Pet Health or any other major buyer, there are three things worth doing. First, understand what your practice actually earns in normalized EBITDA — not just what your tax return says, but what the true operating profit is after the adjustments a qualified buyer’s team will make during their financial review.

Second, understand what the 2026 market pays for a practice with your profile, geography, and doctor count. Third, understand who else is buying in your market right now and what competitive dynamics look like in your specific revenue range.

None of those three things require sharing your financials with Mission first. They require talking to someone who represents your side of the table — not theirs.

Get a Free Mission Pet Health Offer Review →

At Transitions Elite, we work exclusively on the seller side of veterinary practice transactions. When we run a process for a practice owner, we build a field of qualified buyers, run a competitive bidding window inside that field, and work through the final structure with the buyer that’s best for the seller — not the easiest one to close.

Mission Pet Health participates in competitive processes. So do the other major PE-backed buyers active in 2026.

The question is whether your practice goes into that process, or whether you accept a number set by a single buyer in a single conversation. We’re compensated only on the value created — there’s no upfront fee, no retainer, nothing paid unless we close a transaction above what you would have achieved on your own.

If you want to understand what the full market produces for your practice, that’s the conversation to start.


Frequently asked questions

What is Mission Pet Health?

Mission Pet Health is a PE-backed veterinary group formed by the December 2024 merger of Southern Veterinary Partners and Mission Veterinary Partners, with the unified brand launching in July 2025. Shore Capital Partners and Silver Lake are the primary PE sponsors.

As of 2026, Mission Pet Health operates more than 840 hospitals across more than 40 states and is among the largest veterinary platforms in the United States.

Who owns Mission Pet Health in 2026?

Mission Pet Health is majority-owned by Shore Capital Partners, a Chicago-based PE firm that launched Southern Veterinary Partners in 2014 with 3 clinics. Silver Lake joined as a major co-investor in the 2024 recapitalization that valued the combined SVP and MVP platform at approximately $8.6 billion.

Dr. Jay Price, the founder of Southern Veterinary Partners, serves as CEO of Mission Pet Health.

Is Mission Pet Health the same as Southern Veterinary Partners?

Mission Pet Health is the combined successor to both Southern Veterinary Partners and Mission Veterinary Partners. The two platforms formally merged in December 2024.

SVP was founded in 2014 in Birmingham, Alabama; MVP was formed in 2017 in Southfield, Michigan. The unified Mission Pet Health brand launched in July 2025, replacing both prior names.

What does Mission Pet Health’s partnership model mean for sellers in 2026?

Mission Pet Health states that no two partnership structures are the same and offers flexible deal arrangements tailored to each owner’s goals. Their published model commits to not changing a hospital’s name, brand, or culture, and preserves clinical autonomy.

Sellers typically receive a majority cash payment at closing, with the option to retain a portion of equity in the practice or the platform, subject to negotiation.

How long does a Mission Pet Health acquisition take?

Per Mission Pet Health’s published partnership process, valuation of a practice typically takes 30 to 45 days after initial information submission. Closing generally requires 90 to 120 days from a signed letter of intent.

These timelines are for a direct, single-buyer transaction and can compress or extend depending on practice complexity and deal structure.

Should I take a direct Mission Pet Health offer or run a competitive process?

A direct Mission Pet Health offer reflects the leverage in a single-buyer conversation. Running a structured competitive process with multiple qualified bidders surfaces the full range of what your practice can clear in today’s market.

The specific structure and terms of any Mission Pet Health offer are negotiated case by case and become most visible when compared against other qualified bids. Owners who run a competitive process consistently see the total economic outcome expand meaningfully versus a direct offer signed without exploring the broader field.

How many hospitals does Mission Pet Health operate in 2026?

Mission Pet Health operates more than 840 hospitals across more than 40 US states as of 2026, making it one of the largest veterinary platforms in the country. The combined scale reflects the merger of Southern Veterinary Partners (400-plus practices) and Mission Veterinary Partners (330-plus practices), completed in December 2024.

Does Mission Pet Health change a practice’s name or culture after buying it?

Mission Pet Health states explicitly in its published partnership materials that it will not change a hospital’s name, brand, logo, or community impact. The company also states it will not dictate how veterinarians practice medicine or alter a team’s culture.

These commitments are consistent with the legacy SVP partnership model that shaped Mission’s approach to acquisitions.


Sources

Industry M&A research and valuation data

  1. Bloomberg. “Shore Capital, Silver Lake In Talks Over $8.6 Billion Pet-Care Deal.” November 1, 2024. bloomberg.com
  1. Axios. “Private equity preps major veterinary care merger.” November 4, 2024. axios.com
  1. BusinessWire. “FCPT Announces Agreement to Acquire up to 102 Mission Pet Health Veterinary Properties for $268 Million.” May 29, 2026. businesswire.com
  1. The Middle Market. “Shore Capital, Silver Lake Reportedly in Talks Over $8.6B Pet Care Deal.” 2024. themiddlemarket.com

Public company and PE sponsor disclosures

  1. Mission Pet Health. “Southern Veterinary Partners and Mission Veterinary Partners Join Together as Mission Pet Health.” July 21, 2025. missionpethealth.com
  1. GlobeNewswire. “Southern Veterinary Partners and Mission Veterinary Partners Join Together as Mission Pet Health.” July 21, 2025. globenewswire.com
  1. Shore Capital Partners. “Mission Pet Health.” Portfolio company page. shorecp.com
  1. Shore Capital Partners. “Southern Veterinary Partners.” Legacy portfolio page. shorecp.com

Veterinary industry news and practice operations

  1. DVM360. “Merger of veterinary organizations yields a new name.” 2025. dvm360.com
  1. Birmingham Business Journal / Bham Now. “Birmingham’s Southern Veterinary Partners merges to form new national giant.” August 4, 2025. bhamnow.com
  1. Mission Pet Health. “Partnerships.” missionpethealth.com
  1. Connect CRE. “FCPT Snags Mission Pet Health Portfolio Across 31 States.” 2026. connectcre.com